# A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

> **NCT05955261** · PHASE2 · SUSPENDED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Venetoclax
- **DRUG:** Azacitidine
- **DRUG:** Cytarabine
- **DRUG:** Gemtuzumab Ozogamicin
- **DRUG:** Daunorubicin Hydrochloride
- **DRUG:** Fludarabine Phosphate
- **DRUG:** Idarubicin Hydrochloride
- **DRUG:** Mitoxantrone Hydrochloride
- **DRUG:** Etoposide
- **DRUG:** Gilteritinib

## Key facts

- **NCT ID:** NCT05955261
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2023-07-25
- **Primary completion:** 2026-12
- **Final completion:** 2034-03
- **Target enrollment:** 70 (ESTIMATED)
- **Why stopped:** PI requests voluntary hold
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05955261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05955261, "A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05955261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*